15 -7 (57) 2023 — G.X.Rajabova, G.M.Hamidova — FEATURES OF THE COURSE OF ISCHEMIC DISEASE HEART IN METABOLIC SYNDROME

FEATURES OF THE COURSE OF ISCHEMIC DISEASE HEART IN METABOLIC SYNDROME

G.X.Rajabova, Bukhara State Medical Institute named after Abu Ali ibn Sina

G.M.Hamidova, Bukhara State Medical Institute named after Abu Ali ibn Sina

K.Sh.Djumayev Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Probability of developing coronary heart disease (CHD) in patients with metabolic syndrome (MS) significantly increased. Complications of coronary artery disease develop in the presence of MS earlier than in others. IHD against the background of MS and/or diabetes mellitus (DM) is more malignant, up to painless myocardial infarction. IHD associated with glycemic disorders is more likely to result in to unstable angina, myocardial infarction, various arrhythmias. For this category patients develop congestive heart failure faster, diffuse coronary artery disease arteries, including the distal parts of the coronary bed. The presence of MS and DM is a risk factor during cardiac surgery. The effectiveness of therapy for this complication is known largely depends on the timeliness of its detection, which makes it particularly relevant and the importance of the problem of studying risk factors and early diagnosis of metabolic disorders.

Key words: ischemic heart disease; diabetes; metabolic syndrome.

First page

81

Last page

86

For citation: G.X.Rajabova, G.M.Hamidova, K.Sh.Djumayev – FEATURES OF THE COURSE OF ISCHEMIC DISEASE HEART IN METABOLIC SYNDROME //New Day in Medicine 2023 7(57): 81-86 https://newdaymedicine.com/index.php/2023/07/17/l-259/

LIST OF REFERENCES:

  1. Avaliani V.M. New views on the mechanism of development of atherosclerosis: literature review / V. M. Avaliani, V. A. Popov, S. I. Martyushov // Human Ecology. 2005;4:24-29.
  2. Andreev V.V. Character of atherosclerotic lesions of the aorto-arterial bed in metabolic syndrome / V.V. Andreev // Preventive and clinical medicine. 2011;3:64-65.
  3. Bakhshaliev A.B. Atherosclerotic damage to the coronary arteries in angina pectoris with metabolic syndrome: auto-ref. dis. Drs. Honey. Sciences: 14.01.04 / A. B. Bashkhaliev; Institute of Cardiology J. Abdullayev of the Ministry of Health of the Republic of Azerbaijan. – Baku., 2009;25.
  4. Bokarev I.N. About metabolic syndrome / I.N. Bokarev // Clinical experience of the Twenties.  2013;4:6-12.
  5. Bylyeva A.A. Features of the course of acute coronary syndrome in patients with metabolic syndrome: abstract. dis. Cand. Honey. Sciences: 6.01.05 / A. A. Bilyeva; GBOU VPO MGMSU named after A.I. Evdokimova Ministry of Health and Social Development of Russia.-M., 2012;15.
  6. Volkov V.S. Essential arterial hypertension and arterial hypertension in the metabolic syndrome / V.S. Volkov, O.B. Pose-lyugina // Clinical Medicine. 2011;89(2):64-65.
  7. Grigoryan O.A. Menopausal syndrome in women with impaired carbohydrate metabolism: scientific prakich. Hand-in. (2nd ed., Ext.) / O.A. Grigoryan., E.N. Andreeva, I.I. Dedov.- M., 2011;75.
  8. Davydova E.V. Features of the course and treatment of acute coronary syndrome associated with metabolic syndrome: author. dis. Cand. Honey. Sciences: 14.01.04 / E.V. Davydova; GOUVPO “Ural State Medical Academy”.- Yekaterinburg, 2008;15.
  9. Denisenko A.D. Obesity and atherosclerosis: the role of adipokpnov / A. D. Denisenko // Medical Academic Journal. 2010;10(4)45-49.
  10. Nevzorova B.A. et al. Diagnostic assessment of the functional activity of the vascular endothelium in the metabolic syndrome and coronary heart disease / B. A. Nevzorova [et al.] // Cardiovascular therapy and prophylaxis. 2011;10(2):81-87.
  11. Dontsov A.V. Markers of subclinical inflammation in the metabolic syndrome and coronary heart disease / A.V. Dontsov // Scientific statements of Belgorod State University. Series: Medicine. Pharmacy. 2014;25(4):62-64.
  12. Doskina E.V. Hypoglycemia – a predictor of cardiovascular catastrophes / E.V. Doskina, B.M. Tankhilevich // CardioSomatika. 2013;2:67-71.
  13. Evtereva E.D. Cardiorenal relationships and quality of life in patients with chronic heart failure and metabolic syndrome: author. dis. Cand. Honey. Sciences: 14.01.04 / E.D. Evteeva; SBEI HPE “Volgograd State Medical University.” – Volgograd. 2011;13.
  14. Ражабова Г.Х., Рузикулов Х.Ж. (2021). Инновационные алгоритмы первичной и вторичной профилактики метаболического синдрома среди населения пожилого и старческого возраста г. Бухары. // Биология и интегративная медицина, 2021;(2 (49):51-63.
  15. Ражабова Г.Х., Рузикулов Х.Ж. Инновационные алгоритмы первичной и вторичной профилактики метаболического синдрома среди населения пожилого и старческого возраста г. Бухары //Биология и интегративная медицина. 2021;2(49):51-63.
  16. Бадритдинова М.Н., Жураева Х.И., Аслонова Ш.Ж., Ражабова Г.Х. (2015). Распространенность абдоминального ожирения среди населения как основной критерий метаболического синдрома. // Новый день в медицине, 2015;(4):56-59.
  17. Раджабова Г.Х., Джалилова У.Дж. и Нурова Н. (2022). Неинвазивная инструментальная диагностика фиброза печени у пациентов с гепатитом В и С. //Американский журнал экономики и управления бизнесом,2022;5(8):228-234.
  18. Раджабова Г.Х., Джалилова Ю.Дж., Нурова Н. Неинвазивная инструментальная диагностика фиброза печени у больных гепатитом В и С //American Journal of Economics and Business Management. 2022;5(8):228-234.
  19. Kh R.G. Shilajit in medicine (Literature review) //Electronic scientific journal” Biology and Integrative Medicine. 2017;3:131-143.
  20. Kh R.G. (2017). Shilajit in medicine (Literature review). //Electronic scientific journal” Biology and Integrative Medicine, 2017;(3):131-143.

file

download